- Home
- OPI vs HOTH Comparison
OPI vs HOTH Comparison
Compare OPI & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPI
- HOTH
- Stock Information
- Founded
- OPI 2009
- HOTH 2017
- Country
- OPI United States
- HOTH United States
- Employees
- OPI N/A
- HOTH N/A
- Industry
- OPI Real Estate Investment Trusts
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- OPI Real Estate
- HOTH Health Care
- Exchange
- OPI Nasdaq
- HOTH Nasdaq
- Market Cap
- OPI 16.6M
- HOTH 15.6M
- IPO Year
- OPI 2009
- HOTH 2019
- Fundamental
- Price
- OPI $0.22
- HOTH $1.29
- Analyst Decision
- OPI
- HOTH Strong Buy
- Analyst Count
- OPI 0
- HOTH 3
- Target Price
- OPI N/A
- HOTH $4.00
- AVG Volume (30 Days)
- OPI 596.9K
- HOTH 230.9K
- Earning Date
- OPI 07-30-2025
- HOTH 08-12-2025
- Dividend Yield
- OPI 17.95%
- HOTH N/A
- EPS Growth
- OPI N/A
- HOTH N/A
- EPS
- OPI N/A
- HOTH N/A
- Revenue
- OPI $466,972,000.00
- HOTH N/A
- Revenue This Year
- OPI N/A
- HOTH N/A
- Revenue Next Year
- OPI N/A
- HOTH N/A
- P/E Ratio
- OPI N/A
- HOTH N/A
- Revenue Growth
- OPI N/A
- HOTH N/A
- 52 Week Low
- OPI $0.18
- HOTH $0.65
- 52 Week High
- OPI $2.48
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- OPI 42.18
- HOTH 50.80
- Support Level
- OPI $0.23
- HOTH $1.22
- Resistance Level
- OPI $0.25
- HOTH $1.31
- Average True Range (ATR)
- OPI 0.01
- HOTH 0.08
- MACD
- OPI -0.00
- HOTH -0.00
- Stochastic Oscillator
- OPI 12.00
- HOTH 57.69
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).